Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hongcheng Biotechnology is a leading global manufacturer of betaine and its derivatives, serving the pharmaceutical, food, and animal nutrition industries. The company utilizes advanced biological fermentation and chemical synthesis to produce high-purity betaine anhydrous, betaine hydrochloride, and other specialty ingredients. As a major player in the global supply chain, Hongcheng Biotechnology provides essential intermediates for the treatment of metabolic disorders such as homocystinuria. The company operates large-scale, GMP-compliant manufacturing facilities in Shandong, China, and exports its products to markets worldwide. Its commitment to research and development has made it a key partner for international firms seeking high-quality nutritional and pharmaceutical components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hongcheng Biotechnology.